Management of Cystic Fibrosis during COVID-19: Patient Reported Outcomes based remote follow-up among CF patients in Denmark – A feasibility study

Cystic fibrosis (CF) requires frequent outpatient visits with monitoring of lung function, microbiology, and nutritional status. Treatment burden has increased over recent years, and most patients take multiple drugs, several times daily [1]. Treatment regimens including mucolytics, antibiotics, pancreatic enzymes, and insulin, have addressed organ system manifestations rather than treating the underlying ion channel dysfunction. In combination with exercise and physiotherapy, these treatments have been considered to be the best supportive care and have increased life expectancy significantly [2].
Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: Source Type: research